Rheumatology Patient Registry and Biorepository

Recruiting

• Conditions: Rheumatic Diseases; Ankylosing Spondylitis; Psoriatic Arthritis; Reactive Arthritis; Antiphospholipid Syndrome; Giant Cell Arteritis; Polymyalgia Rheumatica; Scleroderma; Systemic Lupus Erythematosus; Behcet Disease

• Registration Number: NCT04402086
• Lead Sponsor: Yale University

Brief Summary

To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.

Detailed Description

A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients seen at Yale clinics diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease.

Study Timeline

• Study First Submitted: 2020-05-20
• Study First Submitted QC: 2020-05-20
• Study First Posted: 2020-05-26
• Study Start: 2020-08-04
• Status Verified: 2023-12
• Last Update Submitted: 2023-12-21
• Last Update Posted: 2024-01-02
• Primary Completion: 2030-06-01
• Study Completion: 2030-06-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Correlate outcomes and biomarkers of rheumatic diseases	10 years	Evaluate clinical data and biospecimens to correlate outcomes and biomarkers of rheumatic diseases.

Trial Locations

Locations (1)

Yale New Haven Hospital; 🇺🇸 New Haven, Connecticut, United States